Literature DB >> 32244060

4-Hydroxynonenal induces Cx46 hemichannel inhibition through its carbonylation.

Mauricio A Retamal1, Mariana C Fiori2, Ainoa Fernandez-Olivares3, Sergio Linsambarth4, Francisca Peña4, Daisy Quintana4, Jimmy Stehberg4, Guillermo A Altenberg2.   

Abstract

Hemichannels formed by connexins mediate the exchange of ions and signaling molecules between the cytoplasm and the extracellular milieu. Under physiological conditions hemichannels have a low open probability, but in certain pathologies their open probability increases, which can result in cell damage. Pathological conditions are characterized by the production of a number of proinflammatory molecules, including 4-hydroxynonenal (4-HNE), one of the most common lipid peroxides produced in response to inflammation and oxidative stress. The aim of this work was to evaluate whether 4-HNE modulates the activity of Cx46 hemichannels. We found that 4-HNE (100 μM) reduced the rate of 4',6-diamino-2-fenilindol (DAPI) uptake through hemichannels formed by recombinant human Cx46 fused to green fluorescent protein, an inhibition that was reversed partially by 10 mM dithiothreitol. Immunoblot analysis showed that the recombinant Cx46 expressed in HeLa cells becomes carbonylated after exposure to 4-HNE, and that 10 mM dithiothreitol reduced its carbonylation. We also found that Cx46 was carbonylated by 4-HNE in the lens of a selenite-induced cataract animal model. The exposure to 100 μM 4-HNE decreased hemichannel currents formed by recombinant rat Cx46 in Xenopus laevis oocytes. This inhibition also occurred in a mutant expressing only the extracellular loop cysteines, suggesting that other Cys are not responsible for the hemichannel inhibition by carbonylation. This work demonstrates for the first time that Cx46 is post-translationally modified by a lipid peroxide and that this modification reduces Cx46 hemichannel activity.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Carbonylation; Cataract; Connexin; Lipid peroxide; Post-translational modification

Mesh:

Substances:

Year:  2020        PMID: 32244060     DOI: 10.1016/j.bbalip.2020.158705

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Cell Biol Lipids        ISSN: 1388-1981            Impact factor:   4.698


  7 in total

1.  Extracellular Cysteines Are Critical to Form Functional Cx46 Hemichannels.

Authors:  Ainoa Fernández-Olivares; Eduardo Durán-Jara; Daniel A Verdugo; Mariana C Fiori; Guillermo A Altenberg; Jimmy Stehberg; Iván Alfaro; Juan Francisco Calderón; Mauricio A Retamal
Journal:  Int J Mol Sci       Date:  2022-06-29       Impact factor: 6.208

Review 2.  Role of ROS/RNS in Preeclampsia: Are Connexins the Missing Piece?

Authors:  María F Rozas-Villanueva; Paola Casanello; Mauricio A Retamal
Journal:  Int J Mol Sci       Date:  2020-06-30       Impact factor: 5.923

Review 3.  Connexin Mutants Compromise the Lens Circulation and Cause Cataracts through Biomineralization.

Authors:  Viviana M Berthoud; Junyuan Gao; Peter J Minogue; Oscar Jara; Richard T Mathias; Eric C Beyer
Journal:  Int J Mol Sci       Date:  2020-08-13       Impact factor: 5.923

Review 4.  Mutations of CX46/CX50 and Cataract Development.

Authors:  Yumeng Shi; Xinbo Li; Jin Yang
Journal:  Front Mol Biosci       Date:  2022-02-11

Review 5.  Role and Posttranslational Regulation of Cx46 Hemichannels and Gap Junction Channels in the Eye Lens.

Authors:  Mauricio A Retamal; Guillermo A Altenberg
Journal:  Front Physiol       Date:  2022-03-30       Impact factor: 4.566

Review 6.  Regulation of Connexin Gap Junctions and Hemichannels by Calcium and Calcium Binding Protein Calmodulin.

Authors:  Zhengping Hu; Manuel A Riquelme; Sumin Gu; Jean X Jiang
Journal:  Int J Mol Sci       Date:  2020-11-02       Impact factor: 5.923

Review 7.  Connexin Gap Junctions and Hemichannels in Modulating Lens Redox Homeostasis and Oxidative Stress in Cataractogenesis.

Authors:  Yumeng Quan; Yu Du; Yuxin Tong; Sumin Gu; Jean X Jiang
Journal:  Antioxidants (Basel)       Date:  2021-08-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.